THSNA 2016 Logo

THSNA Summit 2016 – Register Now

Join us at THSNA Summit 2016 April 14-16 (Pre-Conferences April 14) Chicago, IL       3rd Annual Summit of the Thrombosis & Hemostasis Societies of North America April 14-16, 2016 | Chicago, IL The Thrombosis and Hemostasis Societies of North America (THSNA) will hold its 3rd comprehensive scientific meeting dedicated to thrombosis and hemostasis…

Guidelines icon. Internet button on white background.

New Comprehensive Clinical Guidance in VTE

New detailed consensus guidance from 58 leading experts on treating Venous Thromboembolism (VTE) appears in this month’s Journal of Thrombosis and Thrombolysis and is being made available free, online as open source material. The Anticoagulation Forum initiated this comprehensive guidance project to inform a wide range of healthcare providers about treatments for this life threatening condition and provide easily accessible information about therapies that can…


Medication Safety Campaign Call

Join Jack Ansell, MD, MACP, a member of NBCA’s Medical & Scientific Advisory Board, and NBCA CEO Randy Fenninger, during the upcoming Medication Safety Campaign Call being hosted by the Quality Innovation Network National Coordinating Center (QIN NCC). The event is taking place Tuesday, January 26, 2016, from 3:00-4:00 pm Eastern, and will address the question: Is patient self-management a key…


Navigating Health Insurance Choices

NBCA recently partnered with the National Disability Navigator Resource Collaborative (NDNRC) to provide information on blood clots and how people affected by them may have special health insurance needs.  The purpose of the NDNRC is to provide cross-disability information and support to health insurance navigators and other enrollment specialists thereby ensuring people with disabilities receive…

cdc ha_vte_2

HHS and CDC HA-VTE Prevention Challenge

Healthcare-Associated VTE Prevention Challenge Blood clots affect up to 900,000 people in the United States each year, and cause about 100,000 deaths annually. About half of these blood clots happen after a recent hospital stay or surgery. These types of blood clots are referred to as healthcare-associated venous thromboembolism, or HA-VTE. To support and promote…


Patient Input Needed for New Study Involving APS

The Hemostasis & Thrombosis Center at Duke University Medical Center is leading efforts to develop a clinical trial related to the optimal treatment of venous and arterial thromboembolic events in persons with antiphospholipid syndrome. The team is looking to enlist the help of one or two patients with APS to participate in designing the study….

WTD Symbol (RGB).jpg

World Thrombosis Day HCP Webinar

World Thrombosis Day (WTD) takes place on Tuesday, October 13. In recognition of WTD 2015, the Centers for Disease Control and Prevention (CDC) and the International Society of Thrombosis and Haemostasis (ISTH), are co-hosting a special webinar for healthcare professionals (HCPs) about venous thromboembolism (VTE) and pregnancy. During this webinar, Dr. Andra James will discuss…


New Resources About Healthcare Associated VTE Available from CDC

The Centers for Disease Control and Prevention (CDC) is making available new resources about healthcare associated venous thromboembolism. People who are currently or recently hospitalized, recovering from surgery, or being treated for cancer are at increased risk of developing serious and potentially deadly blood clots. You can access CDC’s main HA-VTE information page by clicking…

Istanbul Conference

Save the Date: 15th International Congress on Antiphospholipid Antibodies

The International Congress on Antiphospholipid Antibodies (aPL) is held every three years to discuss recent advances and future directions in aPL and Antiphospholipid Syndrome (APS). The Local and International Executive Committees extend an invitation to U.S. medical professionals to the 15th International Congress on aPL, which will take place in Istanbul, Turkey, on September 21-24,…

save the date

Webinar for Health Professionals

The National Center on Birth Defects and Developmental Disabilities, Division of Blood Disorders, is hosting an important webinar for health professionals on Thursday, March 19, 2015, from 2:00 pm to 3:00 pm Eastern. Greg Maynard, MD, MSc, SFHM, a member of NBCA’s Medical & Scientific Advisory Board, a hospitalist, and also Clinical Professor of Medicine, and…